NL
TMO icon

Navalign LLC’s Thermo Fisher Scientific TMO Stock Holding History

Navalign LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
2,442
+57
+2% +$27.4K 0.29% 60
2026
Q1 		$1.17M Buy
2,385
+83
+4% +$45K 0.3% 60
2025
Q4 		$1.33M Buy
2,302
+85
+4% +$48.1K 0.33% 50
2025
Q3 		$1.08M Buy
2,217
+54
+2% +$25.1K 0.28% 55
2025
Q2 		$877K Buy
2,163
+21
+1% +$8.78K 0.24% 69
2025
Q1 		$1.07M Buy
2,142
+48
+2% +$26K 0.3% 56
2024
Q4 		$1.09M Buy
2,094
+31
+2% +$17K 0.32% 54
2024
Q3 		$1.28M Buy
2,063
+32
+2% +$18.9K 0.38% 48
2024
Q2 		$1.12M Buy
2,031
+143
+8% +$81.9K 0.35% 50
2024
Q1 		$1.1M Buy
1,888
+149
+9% +$83.6K 0.36% 51
2023
Q4 		$923K Sell
1,739
-212
-11% -$103K 0.32% 61
2023
Q3 		$987K Buy
1,951
+51
+3% +$27.2K 0.37% 54
2023
Q2 		$991K Sell
1,900
-41
-2% -$22.1K 0.4% 45
2023
Q1 		$1.12M Buy
1,941
+77
+4% +$43.4K 0.47% 38
2022
Q4 		$1.03M Sell
1,864
-29
-2% -$15.4K 0.42% 47
2022
Q3 		$960K Buy
1,893
+35
+2% +$19.6K 0.43% 41
2022
Q2 		$1.01M Sell
1,858
-20
-1% -$11K 0.44% 41
2022
Q1 		$977K Sell
1,878
-27
-1% -$15.5K 0.41% 48
2021
Q4 		$1.27M Sell
1,905
-54
-3% -$33.7K 0.51% 37
2021
Q3 		$1.12M Sell
1,959
-460
-19% -$252K 0.47% 44
2021
Q2 		$1.22M Buy
2,419
+29
+1% +$13.7K 0.52% 42
2021
Q1 		$1.09M Buy
+2,390
New +$1.14M 0.48% 44

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Navalign LLC's TMO Position: Q2 2026 in Review

Navalign LLC increased its Thermo Fisher Scientific (TMO) stake by 2.4% in Q2 2026, buying an estimated $27.4K and bringing the position to 2,442 shares worth $1.22M. The position accounts for 0.29% of the portfolio, ranked #60.

Navalign LLC first reported a position in TMO in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.33M in Q4 2025. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Navalign LLC held 2,442 shares of Thermo Fisher Scientific worth $1.22M as of Q2 2026.
  • Navalign LLC bought 57 Thermo Fisher Scientific shares in Q2 2026, an estimated $27.4K.
  • Thermo Fisher Scientific made up 0.29% of Navalign LLC's portfolio in Q2 2026, its #60 holding.
  • Navalign LLC first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 22 quarters since.
  • Navalign LLC's Thermo Fisher Scientific position peaked at $1.33M in Q4 2025.
  • 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Navalign LLC's 13F filing for Q2 2026, filed 28 Jul 2026.